Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca to invest £11.5 million in new clinical oncology bioinformatics collaboration with The University of Manchester
-
AstraZeneca to update on leading lung cancer portfolio at WCLC 2015
-
US FDA approves expanded indication for BRILINTA to include long-term use in patients with a history of heart attack
-
AstraZeneca enters license agreement with Daiichi Sankyo for development and commercialisation of FluMist in Japan
-
Positive Phase III results demonstrate efficacy of antibiotic medicine CAZ-AVI in complicated Urinary Tract Infections
-
AstraZeneca and Valeant Pharmaceuticals to partner on brodalumab
-
PEGASUS-TIMI 54 sub-analysis shows importance of continuing treatment with BRILINTA beyond one year following a heart attack
-
AstraZeneca to present further research into long-term prevention of cardiovascular events for patients with a history of heart attack at ESC Congress 2015
-
AstraZeneca appoints Dr Sean Bohen as Executive Vice President of Global Medicines Development and Chief Medical Officer
-
AstraZeneca and Peregrine Pharmaceuticals to collaborate on immuno-oncology combination clinical trial
Latest articles and press releases
All of our latest press releases and articles are available to explore
